XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue and cost of goods sold        
Total operating revenues $ 4,238 $ 89 $ 8,298 $ 321
Operating expenses:        
Cost of production 1,931 1,834 6,356 4,924
Depreciation and amortization 4,754 1,474 9,329 2,916
Research and development expense 1,960 1,966 3,158 3,158
General and administrative expense 10,608 8,694 21,369 18,061
Project development costs 2,887 2,236 5,846 3,332
Facility idling costs 1,013 0 2,012 0
Total operating expenses 23,153 16,204 48,070 32,391
Loss from operations (18,915) (16,115) (39,772) (32,070)
Other income (expense)        
Interest expense (536) (2) (1,075) (4)
Interest and investment income 5,038 78 8,822 330
Other income (expense), net (7) 2,878 (13) 2,910
Total other income, net 4,495 2,954 7,734 3,236
Net loss $ (14,420) $ (13,161) $ (32,038) $ (28,834)
Net loss per share - basic (in dollars per share) $ (0.06) $ (0.06) $ (0.13) $ (0.14)
Net loss per share - diluted (in dollars per share) $ (0.06) $ (0.06) $ (0.13) $ (0.14)
Weighted-average number of common shares outstanding - basic (in shares) 237,417,618 209,809,994 237,339,583 205,889,651
Weighted-average number of common shares outstanding - diluted (in shares) 237,417,618 209,809,994 237,339,583 205,889,651